Search

Do generics of imatinib jeopardize patient safety for the sake of saving money? An experience in Turkish patients.

 

The high cost of tyrosine kinase inhibitors developed for chronic myeloid leukemia is a major concern for the health care payers, especially in countries with restricted resources.

Read more

Meeting program

EHA ReCon 2025



Read more

Meeting Program

EHA-HKSH Hematology Tutorial 2025



Read more

Research training documents for scholars

CBTH documentsCBTH Non-disclosure Agreement

CRTH documentsCRTH Conditions of Acceptance and Participation

CRTH Non-disclosure Agreement

TRTH documentsTRTH Non-disclosure Agreement

Read more

Meeting Program

EHA-SWG Secondary AML - April 2025



Read more

Register for EHA2025

Get ready to make new connections in Milan from June 12–15, 2025. Register now for EHA's reimagined Congress experience.

Read more